ATM Regulates a RASSF1A-Dependent DNA Damage Response

被引:103
作者
Hamilton, Garth [1 ]
Yee, Karen S. [1 ]
Scrace, Simon [1 ]
O'Neill, Eric [1 ]
机构
[1] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, England
基金
英国医学研究理事会;
关键词
RASSF1A TUMOR-SUPPRESSOR; CELL-CYCLE; P73; PROTEIN; APOPTOSIS; KINASE; CHEMOSENSITIVITY; PROGRESSION; PHENOTYPE; MUTATION;
D O I
10.1016/j.cub.2009.10.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Hypermethylation of CpG islands in the RASSF1 promoter is one of the most frequent events identified in human cancer [1-3]. The epigenetic-driven loss of RASSF1A protein expression is observed more often in tumors of higher grade and correlates with a decreased responsiveness to DNA-damaging therapy [4-6]. Ras association domain-containing family 1A (RASSF1A) promotes apoptosis by signaling through the MST2 and LATS1 kinases, leading to stabilization of the YAP1/p73 transcriptional complex [7]. Here we provide evidence for a new pathway linking DNA damage signaling to RASSF1 A via the main sensor of double-strand breaks in cells, ataxia telangiectasia mutated (ATM). We show that, upon DNA damage, RASSF1 A is phosphorylated by ATM on Ser131 and is involved in the activation of both MST2 and LATS1, leading to the stabilization of p73. Furthermore, lung and ovarian tumor cell lines that retain RASSF1 A expression commonly harbor polymorphisms in the region of Ser131 [8], and our analysis shows that the S131F polymorphism conveys resistance to DNA-damaging agents. Thus, we present a novel DNA damage pathway emanating from ATM that is frequently disabled in tumors via epigenetic silencing of RASSF1 or mutation of an ATM phosphorylation site.
引用
收藏
页码:2020 / 2025
页数:6
相关论文
共 29 条
[1]
Role of the ras-association domain family 1 tumor suppressor gene in human cancers [J].
Agathanggelou, A ;
Cooper, WN ;
Latif, F .
CANCER RESEARCH, 2005, 65 (09) :3497-3508
[2]
A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization [J].
Aylon, Yael ;
Michael, Dan ;
Shmueli, Ayelet ;
Yabuta, Norikazu ;
Nojima, Hiroshi ;
Oren, Moshe .
GENES & DEVELOPMENT, 2006, 20 (19) :2687-2700
[3]
YAP At the crossroad between transformation and tumor suppression [J].
Bertini, Efrem ;
Oka, Tsutomu ;
Sudol, Marius ;
Strano, Sabrina ;
Blandino, Giovanni .
CELL CYCLE, 2009, 8 (01) :49-57
[4]
Regulation of DNA repair throughout the cell cycle [J].
Branzei, Dana ;
Foiani, Marco .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (04) :297-308
[5]
Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression [J].
Burbee, DG ;
Forgacs, E ;
Zöchbauer-Müller, S ;
Shivakumar, L ;
Fong, K ;
Gao, BN ;
Randle, D ;
Kondo, M ;
Virmani, A ;
Bader, S ;
Sekido, Y ;
Latif, F ;
Milchgrub, S ;
Toyooka, S ;
Gazdar, AF ;
Lerman, MI ;
Zabarovsky, E ;
White, M ;
Minna, JD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :691-699
[6]
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma [J].
Catto, JWF ;
Azzouzi, AR ;
Rehman, I ;
Feeley, KM ;
Cross, SS ;
Amira, N ;
Fromont, G ;
Sibony, M ;
Cussenot, O ;
Meuth, M ;
Hamdy, FC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :2903-2910
[7]
ATR: an essential regulator of genome integrity [J].
Cimprich, Karlene A. ;
Cortez, David .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (08) :616-627
[8]
Dmp53 activates the hippo pathway to promote cell death in response to DNA damage [J].
Colombani, Julien ;
Polesello, Cedric ;
Josue, Filipe ;
Tapon, Nicolas .
CURRENT BIOLOGY, 2006, 16 (14) :1453-1458
[9]
The RASSF1A tumor suppressor [J].
Donninger, Howard ;
Vos, Michele D. ;
Clark, Geoffrey J. .
JOURNAL OF CELL SCIENCE, 2007, 120 (18) :3163-3172
[10]
Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine [J].
Dote, H ;
Cerna, D ;
Burgan, WE ;
Carter, DJ ;
Cerra, MA ;
Hollingshead, MG ;
Camphausen, K ;
Tofilon, PJ .
CLINICAL CANCER RESEARCH, 2005, 11 (12) :4571-4579